Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines
Authors
Keywords
Radiation resistance, Head and neck cancer, Kinase inhibitors, STAT5, STAT6
Journal
Molecular Cancer
Volume 12, Issue 1, Pages 133
Publisher
Springer Nature
Online
2013-11-06
DOI
10.1186/1476-4598-12-133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models
- (2013) Hanneke Stegeman et al. RADIOTHERAPY AND ONCOLOGY
- Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck
- (2012) Hanneke Stegeman et al. BMC CANCER
- MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors
- (2012) A. B. Turke et al. CANCER RESEARCH
- Gefitinib Radiosensitizes Stem-Like Glioma Cells: Inhibition of Epidermal Growth Factor Receptor-Akt-DNA-PK Signaling, Accompanied by Inhibition of DNA Double-Strand Break Repair
- (2012) Khong Bee Kang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways
- (2012) Uma Raju et al. RADIOTHERAPY AND ONCOLOGY
- A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies
- (2011) Gabriele Schaefer et al. CANCER CELL
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells
- (2011) H. Xu et al. CLINICAL CANCER RESEARCH
- Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
- (2011) W. Joost Lesterhuis et al. JOURNAL OF CLINICAL INVESTIGATION
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus
- (2011) Gurdeep Marwarha et al. Molecular Neurodegeneration
- Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma
- (2010) Heather D. Brooks et al. CANCER
- Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches
- (2010) Stephen Y. Lai et al. DRUG RESISTANCE UPDATES
- Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism
- (2010) Annette Affolter et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma
- (2009) James A. Bonner et al. RADIOTHERAPY AND ONCOLOGY
- Receptor signaling as a regulatory mechanism of DNA repair
- (2009) Raymond E. Meyn et al. RADIOTHERAPY AND ONCOLOGY
- MAP kinases mediate interleukin-13 effects on calcium signaling in human airway smooth muscle cells
- (2008) Barry Moynihan et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Constitutive Activation of Signal Transducer and Activator of Transcription 5 Contributes to Tumor Growth, Epithelial-Mesenchymal Transition, and Resistance to Epidermal Growth Factor Receptor Targeting
- (2008) P. Koppikar et al. CLINICAL CANCER RESEARCH
- Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer
- (2008) Johan Bussink et al. LANCET ONCOLOGY
- c-Src-p38 Mitogen-Activated Protein Kinase Signaling Is Required for Akt Activation in Response to Ionizing Radiation
- (2008) M.-J. Kim et al. MOLECULAR CANCER RESEARCH
- Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
- (2008) D L Wheeler et al. ONCOGENE
- Signaling networks assembled by oncogenic EGFR and c-Met
- (2008) A. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now